3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Motor Activity
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
16
Filgrastim
15
Etoposide
10
Carboplatin
10
Peripheral Blood Stem Cell Transplantation
8
Melphalan
8
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
Thiotepa
6
Temozolomide
6
Radiotherapy
6
Ifosfamide
6
etoposide phosphate
5
X-Rays
5
Topotecan
5
Phantoms, Imaging
5
Doxorubicin
5
Cisplatin
5
Vincristine
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Mesna
4
selpercatinib
3
sargramostim
3
pembrolizumab
3
palbociclib
3
aldesleukin
3
Sirolimus
3
Radiosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Exercise Therapy
×
CNS
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled